Cargando…
P14 A rare adverse event of eosinophilic fasciitis secondary to immune checkpoint inhibitor therapy
INTRODUCTION: Immune checkpoint inhibitors (ICI) have revolutionised the treatment of solid tumours; however, due to their mechanism of action, they are associated with various immune-related adverse events. Rheumatologists are gaining experience in managing a variety of ICI-induced inflammatory con...
Autores principales: | Byravan, Swetha, Dolan, Lauren, Blake, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532182/ http://dx.doi.org/10.1093/rap/rkad070.035 |
Ejemplares similares
-
Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab
por: Zampeli, Evangelia, et al.
Publicado: (2021) -
Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy
por: Boppana, Sri Harsha, et al.
Publicado: (2021) -
Eosinophilic fasciitis
por: Lamback, Elisa Baranski, et al.
Publicado: (2016) -
Eosinophilic Fasciitis: A Rare Skin Sclerosis
por: Servy, Amandine, et al.
Publicado: (2010) -
An Unusual Presentation of a Rare Disease: Eosinophilic Fasciitis
por: Dakhode, Shubham, et al.
Publicado: (2022)